Roy Bloom is a Nephrology physician affiliated with University of Pennsylvania. OpenAlex indexes 247 publications with 10,870 citations (h-index 59); ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
3400 Spruce St
210 White Building
Philadelphia, PA 191044206
Telephone
215-662-2638Provider last certified this registry record 11 Jul 2022.
Clinical trials
- Myfortic or CellCept Gastrointestinal Effects in African American Kidney Recipients
Sponsor: University of Pennsylvania
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
1 company reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Alexion Pharmaceuticals, Inc.Program year20251 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
NIH funding
1 NIH research award on record, funded 2004–2005 per NIH RePORTER. The latest:
- CO AND C2 IN PREDICTING NEPHROTOXICITY IN STABLE RENAL ALLOGRAFT RECIPIENTS
University of Pennsylvania
FY2005$2,727M01RR000040 - CO and C2 in Predicting Nephrotoxicity in Stable Renal
University of Pennsylvania
FY2004$2,485M01RR000040
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Transplanting hepatitis C virus–infected hearts into uninfected recipients: A single-arm trial
American Journal of Transplantation
2019 - National Trends in Utilization and 1-Year Outcomes with Transplantation of HCV-Viremic Kidneys
Journal of the American Society of Nephrology
2019 - Twelve-Month Outcomes After Transplant of Hepatitis C–Infected Kidneys Into Uninfected Recipients
Annals of Internal Medicine
2018 - Cell-Free DNA and Active Rejection in Kidney Allografts
Journal of the American Society of Nephrology
2017
Similar KOLs
Other experts from the same institution or the same specialty.
Carl June, MD
University of Pennsylvania
Harold Feldman, MD
University of Pennsylvania
Howard Herrmann, MD
University of Pennsylvania
Robert Vonderheide, MD
University of Pennsylvania
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”